BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ghosh SK, Weinberg A. Ramping Up Antimicrobial Peptides Against Severe Acute Respiratory Syndrome Coronavirus-2. Front Mol Biosci 2021;8:620806. [PMID: 34235176 DOI: 10.3389/fmolb.2021.620806] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Tang M, Zhang X, Huang Y, Cheng W, Qu J, Gui S, Li L, Li S. Peptide-based inhibitors hold great promise as the broad-spectrum agents against coronavirus. Front Microbiol 2023;13. [DOI: 10.3389/fmicb.2022.1093646] [Reference Citation Analysis]
2 Behairy MY, Soltan MA, Eldeen MA, Abdulhakim JA, Alnoman MM, Abdel-Daim MM, Otifi H, Al-Qahtani SM, Zaki MSA, Alsharif G, Albogami S, Jafri I, Fayad E, Darwish KM, Elhady SS, Eid RA. HBD-2 variants and SARS-CoV-2: New insights into inter-individual susceptibility. Front Immunol 2022;13:1008463. [PMID: 36569842 DOI: 10.3389/fimmu.2022.1008463] [Reference Citation Analysis]
3 Odolczyk N, Klim J, Podsiadła-białoskórska M, Winiewska-szajewska M, Szolajska E, Zielenkiewicz U, Poznański J, Zielenkiewicz P. Improvement of native structure-based peptides as efficient inhibitors of protein-protein interactions of SARS-CoV-2 spike protein and human ACE2. Front Mol Biosci 2022;9:983014. [DOI: 10.3389/fmolb.2022.983014] [Reference Citation Analysis]
4 Saini J, Kaur P, Malik N, Lakhawat SS, Sharma PK. Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era. Microbiol Res 2022;265:127206. [PMID: 36162150 DOI: 10.1016/j.micres.2022.127206] [Reference Citation Analysis]
5 Tran HTT, Peterburs P, Seibel J, Abramov-sommariva D, Lamy E. In vitro Screening of Herbal Medicinal Products for Their Supportive Curing Potential in the Context of SARS-CoV-2. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-9. [DOI: 10.1155/2022/8038195] [Reference Citation Analysis]
6 Luo X, Zhang T, Tang H, Liu J. Novel electrochemical and electrochemiluminescence dual-modality sensing platform for sensitive determination of antimicrobial peptides based on probe encapsulated liposome and nanochannel array electrode. Front Nutr 2022;9:962736. [PMID: 36046128 DOI: 10.3389/fnut.2022.962736] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
7 Aloul KM, Nielsen JE, Defensor EB, Lin JS, Fortkort JA, Shamloo M, Cirillo JD, Gombart AF, Barron AE. Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis. Front Immunol 2022;13:880961. [DOI: 10.3389/fimmu.2022.880961] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Huțanu A, Georgescu AM, Voidăzan S, Andrejkovits AV, Negrea V, Dobreanu M. Low Serum Vitamin D in COVID-19 Patients Is Not Related to Inflammatory Markers and Patients' Outcomes-A Single-Center Experience and a Brief Review of the Literature. Nutrients 2022;14:1998. [PMID: 35631138 DOI: 10.3390/nu14101998] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Li X, Zuo S, Wang B, Zhang K, Wang Y. Antimicrobial Mechanisms and Clinical Application Prospects of Antimicrobial Peptides. Molecules 2022;27:2675. [PMID: 35566025 DOI: 10.3390/molecules27092675] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Ali W, Elsahn A, Ting DSJ, Dua HS, Mohammed I. Host Defence Peptides: A Potent Alternative to Combat Antimicrobial Resistance in the Era of the COVID-19 Pandemic. Antibiotics 2022;11:475. [DOI: 10.3390/antibiotics11040475] [Reference Citation Analysis]
11 Zhang L, Ghosh SK, Basavarajappa SC, Chen Y, Shrestha P, Penfield J, Brewer A, Ramakrishnan P, Buck M, Weinberg A. HBD-2 binds SARS-CoV-2 RBD and blocks viral entry: Strategy to combat COVID-19. iScience 2022;25:103856. [PMID: 35128350 DOI: 10.1016/j.isci.2022.103856] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
12 Enayathullah MG, Parekh Y, Banu S, Ram S, Nagaraj R, Kumar BK, Idris MM. Gramicidin S and melittin: potential anti-viral therapeutic peptides to treat SARS-CoV-2 infection. Sci Rep 2022;12:3446. [PMID: 35236909 DOI: 10.1038/s41598-022-07341-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 White JH. Emerging Roles of Vitamin D-Induced Antimicrobial Peptides in Antiviral Innate Immunity. Nutrients 2022;14:284. [PMID: 35057465 DOI: 10.3390/nu14020284] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
14 Ciurkiewicz M, Armando F, Schreiner T, de Buhr N, Pilchová V, Krupp-Buzimikic V, Gabriel G, von Köckritz-Blickwede M, Baumgärtner W, Schulz C, Gerhauser I. Ferrets are valuable models for SARS-CoV-2 research. Vet Pathol 2022;:3009858211071012. [PMID: 35001763 DOI: 10.1177/03009858211071012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
15 Althuwaybi AJA, Ward C. Is the lung a complex organ to rebuild? 3D Lung Models for Regenerating Lung Tissue 2022. [DOI: 10.1016/b978-0-323-90871-9.00011-5] [Reference Citation Analysis]
16 Ghalib M, Parekh Y, Banu S, Ram S, Nagaraj R, Kumar BK, Idris MM. Gramicidin S and Melittin - Potential anti-viral therapeutic peptides to treat SARS-CoV-2 infection.. [DOI: 10.1101/2021.10.21.465254] [Reference Citation Analysis]
17 Kongsbak-Wismann M, Al-Jaberi FAH, Schmidt JD, Ghanizada M, Hansen CB, Lopez DV, Woetmann A, Ødum N, Bonefeld CM, Stryhn A, Garred P, Buus S, Geisler C. Normal T and B Cell Responses Against SARS-CoV-2 in a Family With a Non-Functional Vitamin D Receptor: A Case Report. Front Immunol 2021;12:758154. [PMID: 34659264 DOI: 10.3389/fimmu.2021.758154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Grant WB, Lordan R. Vitamin D for COVID-19 on Trial: An Update on Prevention and Therapeutic Application. Endocr Pract 2021:S1530-891X(21)01260-X. [PMID: 34648940 DOI: 10.1016/j.eprac.2021.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
19 Ismailova A, White JH. Vitamin D, infections and immunity. Rev Endocr Metab Disord 2021. [PMID: 34322844 DOI: 10.1007/s11154-021-09679-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 10.5] [Reference Citation Analysis]